Q4 2020 Acorda Therapeutics Inc Earnings Call Transcript

Mar 04, 2021 / 09:30PM GMT
Operator

Welcome to Acorda Therapeutics Fourth Quarter and Year-End 2020 Financial and Business Update. (Operator Instructions) Please be advised that this call is being recorded at the company's request.

I will now introduce your host for today's call, Ms. Tierney Saccavino, Executive Vice President, Corporate Communications at Acorda. Ma'am, please go ahead.

Tierney Saccavino - Acorda Therapeutics, Inc. - EVP of Corporate Communications

Thank you, Joanna. Good afternoon, everyone.

Before we begin, let me remind you that this presentation will contain forward-looking statements. Detailed disclosures can be found in our SEC filings, which are public, and we encourage you to refer to those filings.

I will now pass the call over to our CEO, Ron Cohen.

Ron Cohen - Acorda Therapeutics, Inc. - Founder, CEO, President & Director

Thank you, Tierney, and welcome, everyone. We'll go right into INBRIJA net revenue for the full year 2020, which was $24.2 million. And for the fourth quarter, net revenue

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot